Sign in

Ashish Verma

@ashunephro.bsky.social
328 followers 261 following 14 posts

Clinician Scientist at Boston University Chobanian & Avedisian School of Medicine. Nephrologist at Boston Medical Center and BU Amyloidosis center profiles.bu.edu/Ashish.Verma

PostsRepliesMedia
Reposted by Ashish Verma
American Journal of Kidney Diseases @ajkd.bsky.social · 15/09/2026
Joint Impact of Aldosterone and Low-Density Lipoprotein Cholesterol on Cardiovascular Risk in CKD bit.ly/4A2iUvt
Restricted cubic spline plota,b,c,d of the association of serum aldosterone with major cardiovascular events (MACE) across levels of low-density lipoprotein (LDL) in persons with CKD and without baseline cardiovascular disease aThe plot depicts the hazard ratio for each doubling of serum aldosterone across varying levels of LDL. Hazard ratios are calculated using LDL = 70 mg/dL as the reference. The solid line represents the estimated hazard ratio, while the shaded area indicates the 95% confidence interval.
011
Reposted by Ashish Verma
MedPage Today @medpagetoday.com · 13/07/2026
The prevalence of CKD in the U.S. was generally stable over the past decade, but the underlying diagnoses driving the condition changed over time. @ashunephro.bsky.social @sophieclaudel.bsky.social www.medpagetoday.com/nephrology/gen…
medpagetoday.com
Chronic Kidney Disease Increasingly Driven by Diabetes
Despite treatment advances, kidney disease burden remained unchanged over the past decade
012
Reposted by Ashish Verma
NEJM.org @nejm.org · 12/07/2026
Updated estimates of the prevalence of chronic kidney disease (CKD) in the United States indicate that the overall national burden of CKD has remained stable, but an increasing proportion is associated with diabetes. Learn more: nej.md/4wxMc2f
0103
Ashish Verma @ashunephro.bsky.social · 09/07/2026
CKD prevalence in the U.S. hasn't changed in a decade from 14.5% in 2013 to 14.8% in 2023 affecting ~36 million adults. @nejm.org But the disease underneath has changed: diabetes-linked CKD is up 29%. @sophieclaudel.bsky.social www.nejm.org/doi/full/10....
nejm.org
Trends and Prevalence of Chronic Kidney Disease in the United States | NEJM
Updated estimates of the prevalence of CKD in the United States indicate that the overall national burden of CKD has remained stable, but an increasing proportion is associated with diabetes.
000
Ashish Verma @ashunephro.bsky.social · 02/03/2026
Prevalence of Albuminuria Across Cardiovascular‐Kidney‐Metabolic Phenotypes in the United States - Claudel - Diabetes, Obesity and Metabolism - Wiley Online Library dom-pubs.onlinelibrary.wiley.com/doi/10.1111/... @sophieclaudel.bsky.social
dom-pubs.onlinelibrary.wiley.com
Prevalence of Albuminuria Across Cardiovascular‐Kidney‐Metabolic Phenotypes in the United States
Click on the article title to read more.
000
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 26/11/2025
I’m very proud of this work and our efforts to make albuminuria evaluation and management accessible to primary care clinicians. Thank you to @ashunephro.bsky.social and our co-authors for the mentorship, and to the @bmj.com for supporting our work!
021
Reposted by Ashish Verma
The BMJ @bmj.com · 26/11/2025
Low rates of testing could mean that up to two thirds of people at risk for chronic kidney disease may have unrecognised albuminuria. What should doctors know about interpretation, treatment, & follow-up? Includes a visual summary - click the link to view in full #MedEd www.bmj.com/content/391/...
0164
Ashish Verma @ashunephro.bsky.social · 25/11/2025
Headline: Albuminuria: The "Silent" Risk We Can’t Afford to Miss in Primary Care I am excited to share our latest article, published today in @bmj.com led by @sophieclaudel.bsky.social : "Assessment and management of albuminuria in adults." bmj.com/cgi/content/...
021
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 15/10/2025
I’m extremely honored to have been chosen as one of this year’s STAT Wunderkinds and grateful for the incredible support of my mentors @ashunephro.bsky.social and Sus Waikar!! @bu_bmc_renal 🎉 #nephsky www.statnews.com/wunderkinds/
statnews.com
142
Reposted by Ashish Verma
ASN Publications @asnpublications.bsky.social · 17/09/2025
Foot Process Effacement (FPE) could serve as a valuable marker for assessing the risk of disease progression across various kidney pathologies. Read more in #ASNKidney360: kidney.pub/KID0894 @ashunephro.bsky.social @sophieclaudel.bsky.social
062
Ashish Verma @ashunephro.bsky.social · 09/09/2025
Our article, “Cumulative Incidence of Mortality Associated with Cardiovascular–Kidney–Metabolic (CKM) Syndrome,” published in JASN @sophieclaudel.bsky.social @asnpublications.bsky.social has been selected for the “Best of ASN Journals at KidneyWeek 2025. journals.lww.com/jasn/fulltex...
journals.lww.com
Cumulative Incidence of Mortality Associated with... : Journal of the American Society of Nephrology
and risk mitigation.CKM staging is specific to cardiovascular mortality, given lack of a strong association with either noncardiovascular or cancer mortality. Background It is imperative to critica...
052
Reposted by Ashish Verma
ASN Publications @asnpublications.bsky.social · 17/07/2025
Despite repeating proteinuria measurements throughout a patient with CKD's clinical course, clinicians may overlook important temporal patterns that emerge. Read more about proteinuria trajectories and risk of adverse clinical outcomes: kidney.pub/KID0849 #ASNKidney360 @ashunephro.bsky.social
041
Reposted by Ashish Verma
Frank Harrell @f2harrell.bsky.social · 15/04/2025
Milestone release of #rstats rms package is now on CRAN with a full suite of survival analysis fitting, validation, and graphical display functions based on semiparametric models, generalizing the Cox PH model to a spectrum of models including accelerated failure time. hbiostat.org/r/rms #StatsSky
hbiostat.org
RMS
0407
Ashish Verma @ashunephro.bsky.social · 15/04/2025
Excited to share our comprehensive review “Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations” #CardiologyClinics @sophieclaudel.bsky.social @ahascience.bsky.social @asnkidney.bsky.social kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...
120
Reposted by Ashish Verma
Kidney Medicine Journal @kidneymed.bsky.social · 05/04/2025
Genetic Testing in Biopsy-Confirmed Kidney Disease
kidneymedicinejournal.org
053
Reposted by Ashish Verma
ASN Publications @asnpublications.bsky.social · 28/03/2025
Cardiovascular–kidney–metabolic (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. bit.ly/JASN0637 #ASNJASN @ashunephro.bsky.social @sophieclaudel.bsky.social
061
Reposted by Ashish Verma
ASN Publications @asnpublications.bsky.social · 27/03/2025
Cumulative Incidence of Mortality (CKM) syndrome stages 1 to 4 are associated with a graded risk of cardiovascular mortality in a nationally representative sample of U.S. adults. bit.ly/JASN0637 #ASNJASN @ashunephro.bsky.social @sophieclaudel.bsky.social
152
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 25/03/2025
Learned quite a lot about interactions, thresholds, and synergistic effects from @ashunephro.bsky.social in this analysis of albuminuria, heart failure, and CKD progression. Our findings emphasize albuminuria as a key biomarker for CKM health. 🫘 @jaccjournals.bsky.social #NephSky
031
Ashish Verma @ashunephro.bsky.social · 24/03/2025
Delighted to share our study published in @jaccjournals.bsky.social led by @sophieclaudel.bsky.social. We demonstrated deleterious synergy between albuminuria and heart failure as risk factors for CKD progression. www.jacc.org/doi/10.1016/...
2115
Reposted by Ashish Verma
Edgar V. Lerma 🇵🇭 @edgarvlermamd.medsky.network · 16/03/2025
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review ca. 2025 #Nephpearls #NephSky 👉🏼 pubmed.ncbi.nlm.nih.gov/40063723/
0172
Reposted by Ashish Verma
Prof Claire Hills @chillslincoln79.bsky.social · 12/03/2025
Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review 👩‍🔬🥼🧪👨‍🔬 #CardioSky #NephSky #cardiovascular #cardio-renal #metabolicdisorder #KidneyResearch #kidneydisease 👇👇👇 www.ahajournals.org/doi/epub/10....
ahajournals.org
093
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 11/03/2025
Extremely grateful to @ahascience.bsky.social and @ashunephro.bsky.social for the opportunity to publish this comprehensive review on albuminuria in #Circulation. We cover albuminuria in the spectrum of #CKM disorders. Please take a look! @nephjc.bsky.social #NephSky
033
Ashish Verma @ashunephro.bsky.social · 10/03/2025
Thank you for highlighting our review!!!
030
Ashish Verma @ashunephro.bsky.social · 10/03/2025
Thrilled to share our state of art review led by extraordinary @sophieclaudel.bsky.social “Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review" www.ahajournals.org/eprint/SXXGK... @ahascience.bsky.social @ahajournals.bsky.social @asnkidney.bsky.social
2136
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 22/02/2025
Excited to share this research letter looking at albuminuria values in healthy adults! We followed IFCC guidelines for establishing references ranges, which had not previously been shown in the literature, and consider what “normal” should be by sex.
011
Ashish Verma @ashunephro.bsky.social · 21/02/2025
We sought to quantify the upper limit of normal for albuminuria among US adults by the IFCC standard. Our study led by @sophieclaudel.bsky.social “Albuminuria References Ranges in Healthy US Adults” academic.oup.com/jalm/advance...
academic.oup.com
Albuminuria References Ranges in Healthy US Adults
To the Editor:
020
Ashish Verma @ashunephro.bsky.social · 11/02/2025
Thrilled to share our publication led by exceptional @sophieclaudel.bsky.social "Cumulative Incidence of Mortality Associated with Cardiovascular-Kidney-Metabolic Syndrome" in @asnpublications.bsky.social journals.lww.com/jasn/abstrac... @asnkidney.bsky.social @americanheart.bsky.social
journals.lww.com
Cumulative Incidence of Mortality Associated with... : Journal of the American Society of Nephrology
e corresponding restricted mean survival time over a 15-year period. Methods: This is a longitudinal study of 50,678 community-dwelling U.S. adults aged 20 and older with baseline data for CKM stag...
021
Ashish Verma @ashunephro.bsky.social · 07/01/2025
Our comprehensive review on “ Diuretics in patients with chronic kidney disease” @natrevneph.bsky.social
073
Ashish Verma @ashunephro.bsky.social · 06/01/2025
Adults with higher levels of albuminuria within the low range (UACR <30 mg/g) and no major cardiovascular risk factors have higher risks of cardiovascular and all-cause mortality. academic.oup.com/eurjpc/artic... @sophieclaudel.bsky.social
060
Reposted by Ashish Verma
Sophie Claudel, MD @sophieclaudel.bsky.social · 12/12/2024
Very excited to share this work by my mentor Dr. Ashish Verma and me on #SDOH and #mortality among adults *without* major chronic diseases published in @JGIM! We looked at food insecurity, employment, income, acculturation, education and healthcare access. link.springer.com/article/10.1...
link.springer.com
Social Determinants of Health and Cumulative Incidence of Mortality Among US Adults Without Major Chronic Diseases - Journal of General Internal Medicine
Background Social determinants of health (SDOH) are associated with poor health outcomes among individuals with prevalent diseases. Objective To quantify the association between adverse SDOH and morta...
021